Published November, 2012
By H.-J. Schuurman, G. Feutren and J.-F. Bach
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Expanding from the classic use of immunosuppressants in transplantation and rejection, this current overview highlights their new roles in clinical medicine.

---

Published November, 2012
By Eric Ertel and Théophile Godfraind
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

The main effect of calcium channel blockers is the blockade of calcium entry into cells through voltage operated calcium channels. This volume gives a comprehensive overview of the different classes of CCBs and their various effects. It covers historical development, pharmacology, clinical aspects, and perspectives.

---

Published November, 2012
By Michel Pairet and Joanne van Ryn
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

COX-2 inhibitors are important drugs with analgesic and anti-inflammatory effects. This book presents both pre-clinical and clinical information and is important for clinicians interested in the latest information about this class of drugs, for researchers and for students in the field.

---

Published October, 2012
By Michael Torzewski and Gerd Schmitz
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins.

---

Published October, 2012
By Joseph M. Colacino and Beverly A. Heinz
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

---

Published October, 2012
By Bruce N. Cronstein, Joseph R. Bertino and Bruce Cronstein
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Although surprising, it seems fitting that a drug developed at the dawn of the era of rational drug design and therapeutics, methotrexate, should remain in common use for the therapy of so many different kinds of illnesses.

---

Published October, 2012
By Udo Dunzendorfer
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

---

Published October, 2012
By David Nutt and Mike Briley
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating: 1.00
Availability: Available

In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD).

---

Published October, 2012
By Allan R. Ronald and Donald Low
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

---

Published October, 2012
By Alexander R. Cools and Bart A. Ellenbroek
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra pyramidal) side-effects were the most troublesome.

---